In 2023, Gail K. Boudreaux earned $6.09M in total compensation at Elevance Health, including $1.60M salary and $3.65M bonus. Most recently acquired 52,414 shares in Mar 2025. Currently holds stock worth $112.44M. Has donated $15.19M in stock to charitable causes. 8+ years at the helm of Elevance Health.
Compensation History
Annual executive compensation data for Gail K. Boudreaux, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$6.09M
Salary
$1.60M
Bonus
$3.65M
Other
$840.96K
Salary
$1.60MBoard Justification
The compensation philosophy emphasizes performance-based compensation, aligning executive interests with shareholder interests through a mix of fixed and variable compensation, with a significant portion tied to long-term performance.
Bonus
$3.65MBoard Justification
Based on Company performance, the awards earned as a percentage of their respective target awards for 2023 were 114% for Ms. Boudreaux.
Other Compensation
$840.96KBoard Justification
Includes tax equalization payments, corporate aircraft usage, and other perquisites.
Restricted Stock
Board Justification
No stock grants were vested in 2023 as the focus is on performance-based compensation and long-term incentives.
Performance Metrics
The performance metrics for determining compensation included Adjusted Net Income, Operating Revenue, and various operational performance measures.
Gail K. Boudreaux
CEO of Elevance Health
Education
MBA from Columbia Business School.
Field of Expertise
Healthcare & Life Sciences - Healthcare
Sector of Economy
Healthcare
Born
June 1, 1960 - 65 years ago
CEO of Elevance Health for
8 years 0 months (Nov 2017 - Present)
Previous Experience
CEO of GKB Global Health, LLC and Executive Vice President of United HealthGroup.
Other Elevance Health CEOs
Holdings
Track Gail K. Boudreaux's stock holdings and portfolio value over time.
Total Stock Sold
$42.46M
$25.33M
432,768 UNH shares
$17.13M
34,000 ELV shares
What if they kept their stock?
If Gail K. Boudreaux didn't sell their stock, today they would have:
Extra UNH432,768 shares worth $144.32M and ELV34,000 shares worth $11.34M.
This is 266.61% and $113.20M more than what they got when they sold the stock.
Charitable Transactions
35,542 shares
UNH
10,000 shares
ELV
Recent Charitable Transactions
10,000 shares
ELV
Nov 4, 2022
Charity
2,771 shares
UNH
Mar 26, 2012
Charity
32,771 shares
UNH
Feb 5, 2009
Charity
Insider Trading
Gail K. Boudreaux's recent stock transactions, purchases, and sales filed with the SEC.
52,414 shares
ELV
Mar 3, 2025
Received
$17.06M
ELV at $501.74/share
Jul 22, 2024
Sale
42,932 shares
ELV
Mar 1, 2024
Received
44,297 shares
ELV
Mar 1, 2023
Received
10,000 shares
ELV
Nov 4, 2022
Charity
657.185 shares
UNH
Sep 23, 2014
Received
687.972 shares
UNH
Jun 25, 2014
Received
519.746 shares
UNH
Mar 25, 2014
Received
$6.88M
UNH at $76.09/share
Feb 27, 2014
Sale
$7.76M
UNH at $46.83/share
Feb 12, 2014
Received
Rivals
Compare Gail K. Boudreaux with competitor CEOs and industry peers.
Joseph M. Zubretsky
CEO of Molina Healthcare
2023 Compensation
Stock
$1.15M
Salary
$1.10M
Bonus
$2.04M
Other
$87.75K
Total Holdings
$556.20M
Sir Andrew P. Witty
CEO of UnitedHealth Group
2024 Compensation
Stock
$13.09M
Salary
$1.50M
Bonus
$0.00
Other
$339.10K
Total Holdings
$47.23M
Sarah M. London
CEO of Centene
2023 Compensation
Stock
$0.00
Salary
$1.40M
Bonus
$2.79M
Other
$285.34K
Total Holdings
$73.05M